This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,453.36 firm fixed-price delivery order is for the supply of 4,566,490,419 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held...
This federal contract award is a $1,075.66 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,392 units of the prescription medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of August 9, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,053.34 firm fixed-price delivery order is for the supply of 100 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,874.93 firm fixed-price delivery order contract is for the supply of 4,566,693,094 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,586.00 firm fixed price delivery order is for the supply of 4,566,150,315 units of the prescription drug Vyvanse 50 mg capsules. The contract has an ultimate completion date of October 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,868.93 firm fixed-price delivery order is for the supply of 4,565,639,987 Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,841.60 firm fixed-price delivery order is for the supply of 100 units of the medication Vyvanse 20 mg capsule. The award has a completion date of February 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,738.42 firm fixed-price delivery order is for the supply of Vyvanse 30 mg capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...